Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 97,300 | 93,200 | 79,094 | 92,714 | 74,800 |
| Cost of Goods | 7,100 | 9,000 | 8,323 | 12,213 | 6,800 |
| Gross Profit | 90,200 | 84,200 | 70,771 | 80,501 | 68,000 |
| Operating Expenses | 74,500 | 73,400 | 78,138 | 74,023 | 64,700 |
| Operating Income | 15,800 | 10,800 | -7,044 | 6,691 | 4,100 |
| Other Income | -3,100 | -3,700 | -4,744 | 41 | -2,600 |
| Pre-tax Income | 12,700 | 7,100 | -11,788 | 6,732 | 1,500 |
| Income Tax | 5,200 | 2,500 | 3,100 | 3,925 | 2,500 |
| Net Income Continuous | 7,500 | 4,600 | -14,888 | 2,807 | -1,000 |
| Minority Interests | N/A | N/A | -169 | N/A | N/A |
| Net Income | $7,500 | $4,600 | $-14,719 | $2,907 | $-1,100 |
| EPS Basic Total Ops | 0.11 | 0.07 | -0.22 | 0.05 | -0.02 |
| EPS Basic Continuous Ops | 0.11 | 0.07 | -0.22 | 0.05 | -0.02 |
| EPS Diluted Total Ops | 0.10 | 0.06 | -0.22 | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | 0.10 | 0.06 | -0.22 | 0.08 | -0.02 |
| EPS Diluted Before Non-Recurring Items | 0.10 | 0.06 | -0.22 | 0.05 | -0.02 |
| EBITDA(a) | $18,526 | $13,502 | $-4,462 | $14,390 | $6,843 |